Bellicum Pharmaceuticals names CFO

WORKFLOW SOLUTIONS
PRODUCTS
See More S&P Global Solutions
CONTENT
PODCASTS
SEE ALL EPISODES
SECTOR-SPECIFIC INSIGHTS
More ways we can help
NEWS & RESEARCH TOPICS
See More
Featured Events
Webinar Accelerated IR: 2024 Strategy – Planning, Executing & Measuring Success for the Year Ahead
- 10/04/2023
- Live, Online
- 11:00 am - 12:00 pm EDT
WebinarAdvancing LGBTQ+ Inclusion in Global Organizations: Insights from ESG Filings
- 10/05/2023
- Live, Online
- 11:00 am - 12:00 pm EDT
In PersonHosting and Cloud Transformation Summit 2023
- 10/10/2023
- SECOND, NYC, 849 6th Ave, New York
- 7:30am – 6:30pm EDT
PLATFORMS
OTHER PRODUCTS
- Research Online
- 451 Research
See All Product Logins

In This List

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises

Blog

Essential IR Insights Newsletter - Summer July-August 2023

Blog

Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits

13 Dec, 2018

Author Fatima Aitizaz
Theme Healthcare & Pharmaceuticals

Bellicum Pharmaceuticals Inc. named Atabak Mokari CFO, effective Dec. 19.

Mokari was CFO and vice president corporate development at IRIDEX Corp., an ophthalmic medical technology company.

Houston-based Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that develops novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders.